OasisLMS

This course explores best practices for improving care coordination in early-stage non-small cell lung cancer (NSCLC), with a focus on biomarker testing, multidisciplinary treatment planning, and patient navigation. Learners will examine strategies to optimize timely molecular testing, support personalized treatment decisions, and strengthen collaboration across the care team to improve patient outcomes.

• Understand the role of biomarker testing in the diagnosis and treatment of early-stage NSCLC
• Recognize the benefits and challenges of neoadjuvant and adjuvant therapies, including immunotherapy and targeted therapies.
• Identify effective strategies for patient navigation, care coordination, and symptom management to improve patient comfort and enhance patient outcomes.
• Apply insights from multidisciplinary care teams to improve patient care and streamline the treatment process for early-stage NSCLC.

Joseph Kim, MD, MPH, MBA (Moderator)
Moderator, President of Xaf Solutions
Association of Cancer Care Centers Consultant




Michelle Shiller, DO, AP, CP, MGP, FACP
Medical Director, Genomic and Molecular Pathology Services
Baylor Scott & White Health



Jennifer Aversano, MSN, RN, OCN, ONN-CG
Oncology Nurse Lung Navigator
Northwest Community Hospital



Thomas Lycan, DO, MHS
Associate Professor, Hematology and Oncology
Atrium Health Wake Forest Baptist